Finance

Lists
MED:NYSE
Medifast Inc
$12.53
-0.32%
(-0.040) 1D
Nov 2, 4:00:02 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MED...
Mkt. cap
139.88M
Avg. vol.
126.22K
Volume
1.00
52-wk high
$13.45
52-wk low
$9.22
EPS
-$3.69
Beta
0.65
Shares outstanding
11.18M
No. of employees
380
Mkt. cap
139.88M
Avg. vol.
126.22K
Volume
1.00
52-wk high
$13.45
52-wk low
$9.22
EPS
-$3.69
Beta
0.65
Shares outstanding
11.18M
No. of employees
380
News stories
From web sources and news partners
Profile
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics. Wikipedia
About Medifast Inc
CEODaniel R. Chard | Daniel R. Chard
Employees380
Founded1981
Headquarters-
SectorPersonal care products
Analyst ratings
Based on 1 analyst giving stock ratings to MED in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for MED in the last 3 months
Highest
Current $12.53
$12.00 (-4.23%)
Average
$12.00 (-4.23%)
Lowest
$12.00 (-4.23%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Stephens
Hold
Maintained
$12.00
-4.2%
10/27/2026
Jim Salera
Stephens
Hold
Maintained
$12.00
-4.2%
10/27/2026
Last report
Oct 26, 2026
Fiscal period
Q3 2026
-$0.19 / -$0.35
+45.71%beat
Revenue / Est. (USD)
72.05M / 71.30M
+1.05%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
75.10M
76.04M
76.38M
72.05M
Cost of goods sold
22.96M
24.29M
22.99M
22.01M
Cost of revenue
22.96M
24.29M
22.99M
22.01M
Research and development expenses
1.00M
1.10M
-
2.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
58.94M
56.14M
57.72M
66.60M
Operating expense
59.94M
57.24M
57.72M
69.40M
Total operating expenses
82.90M
81.52M
80.71M
91.41M
Operating income
-7.80M
-5.48M
-4.33M
-19.36M
Other non operating income
1.00K
16.00K
-11.00K
15.00K
EBT including unusual items
-6.38M
-1.94M
-2.99M
-17.84M
EBT excluding unusual items
-6.38M
-4.08M
-2.99M
-17.84M
Income tax expense
11.74M
181.00K
109.00K
-324.00K
Effective tax rate
-183.91%
-9.32%
-3.64%
1.82%
Other operating expenses
-
-
-
-
Net income
-18.12M
-2.12M
-3.10M
-17.51M
Net profit margin
-24.13%
-2.79%
-4.06%
-24.30%
Earnings per share
-1.65
-0.19
-0.28
-0.19
Interest and investment income
1.42M
1.38M
1.35M
1.51M
Interest expense
-
-
-
-
Net interest expenses
1.42M
1.38M
1.35M
1.51M
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.34M
-2.00M
-881.00K
-17.00M
Gain or loss from assets sale
372.00K
-2.12M
-
362.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps